| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Pelcitoclax | BM-1252; APG-1252 | Phase 2 Clinical | Jiangsu Yasheng Pharmaceutical Development Co Ltd | Solid tumours; Ovarian Neoplasms; Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lymphoma, Extranodal NK-T-Cell; Primary Myelofibrosis; Peritoneal Neoplasms; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Uterine Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Endometrioid | Details |
| TGRX-814 | TGRX-814 | Phase 2 Clinical | Hematologic Neoplasms; Leukemia; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoma | Details | |
| LP-118 | LP-118 | Phase 2 Clinical | Guangzhou Lupeng Pharmaceutical Co Ltd, Newave Pharmaceutical Inc | Lymphoma, B-Cell; Solid tumours; Leukemia; Bone Marrow Neoplasms; Neoplasms; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Richter's Syndrome; Primary Myelofibrosis; Leukemia, Prolymphocytic, T-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
| UBX-1325 | UBX-1325 | Phase 2 Clinical | Unity Biotechnology Inc, Ascentage Pharma Group International | Macular Edema; Diabetic macular oedema; Macular Degeneration | Details |
| Mirzotamab clezutoclax | ABBV-155 | Phase 1 Clinical | Abbvie Inc | Solid tumours | Details |
| DT-2216 | DT-2216 | Phase 1 Clinical | University Of Florida, Dialectic Therapeutics Inc | Hematologic Neoplasms; Solid tumours | Details |
| ABBV-637 | ABBV-637 | Phase 1 Clinical | Abbvie Inc | Solid tumours; Carcinoma, Non-Small-Cell Lung | Details |
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Gossypol acetic acid/Potassium Chloride/Vitamin B1/Vitamin B6 | Approved | Mainland China | Uterine Hemorrhage; Uterine Neoplasms; Endometriosis | Xi'An Beifang Medicine Co Ltd | 1988-01-01 | Endometriosis; Uterine Hemorrhage; Uterine Neoplasms | Details | |||
| R-(-)-gossypol acetic acid | AT-101; BL-193; TW-37; NSC-726190 | Approved | University Of Michigan, Jiangsu Yasheng Pharmaceutical Development Co Ltd, National Institutes Of Health | Mainland China | Contraception; Genital Diseases, Female | Shanxi Panlong Pharmaceutical Group Limited By Share Ltd | 2002-01-01 | Esophageal Neoplasms; Contraception; Genital Diseases, Female; Glioblastoma; Lymphoma, Large B-Cell, Diffuse; Small Cell Lung Carcinoma; Adrenocortical Carcinoma; Prostatic Neoplasms; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Brain Neoplasms; Gliosarcoma; Leukemia, Lymphocytic, Chronic, B-Cell | Details |




